Launch of UNITE4TB partnership marks a new era in Tuberculosis treatment development

Scientists from the University of St Andrews Infection and Global Health Research Division at the School of Medicine will play a key role in UNITE4TB, a global partnership to accelerate the development of new Tuberculosis (TB) drug regimens, as part of …

15th July 2021 | igh


European Society for Clinical Microbiology and Infectious Diseases Symposium

Stephen Gillespie joined distinguished international colleagues on a European Society for Clinical Microbiology and Infectious Diseases (ESCMID) Symposium “Tuberculosis: Bringing new science to diagnostics”.  Speaking were Professors Ulrika Simmonson from University of Uppsala (Pharmacometrics) Jan-Willem Alffenaar from the University of …

19th May 2021 | igh


World TB Day – 24 March 2021

Globally, Tuberculosis (TB) is the leading cause of death from a single infectious disease agent.  Our sustained research in St Andrews over the last 10 years (on the disease and the pathogen responsible) has developed global capacity to improve tuberculosis …

24th March 2021 | igh


Funding awarded for TB research

The St Andrews tuberculosis research group together with global health partners have won a €4.9 million grant from the European Developing Countries Clinical Trials Partnership (EDCTP).  Led by Prof Kogieleum Naidoo, of CAPRISA in Kwa-Zulu Natal, the TRiAD consortium seeks to determine how …

29th December 2020 | igh


Visit from Dr Sekaggya-Wiltshire

The Infection and Global Health Division recently welcome Dr Christine Sekaggya-Wiltshire and Dr Olive Mbabazi from Makarere University.

14th May 2019 | news


Scientists revolutionise treatment of tuberculosis

New medical advances could revolutionise the ability to treat undetected tuberculosis (TB) thanks to an international team of scientists led by the University of St Andrews.

6th February 2019 | news


New trial to combat TB

Scientists at the School of Medicine are leading the medical monitoring of a new clinical trial to treat tuberculosis more quickly.

5th September 2018 | news


Innovative diagnostic test for tuberculosis could save millions of lives

LifeArc and the Infection Group, led by Professor Stephen Gillespie announced a partnership to develop a molecular diagnostic test for the detection and quantification of tuberculosis (TB) bacteria in patients.

8th August 2018 | news


MBLA Conference

the first ever Molecular bacterial load assay (MBLA) stakeholders conference was held at the University of St Andrews, 11th – 13th June 2018.

25th June 2018 | news


MBLA Conference

Experts from around the world are gathered in St Andrews to learn how to dramatically cut the time needed to diagnose tuberculosis to save hundreds of thousands of lives.

13th June 2018 | news